Pharmacotherapy of aphasia: Myth or reality?

Xavier de Boissezon, Patrice Peran, Chloé de Boysson, Jean François Démonet

Research output: Contribution to journalArticlepeer-review


Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents. Here, we reviewed the MEDLINE available reports of drug therapy for aphasia. So far, proofs of efficiency were found indubitable for none of the studied molecules. However, some of them showed limited efficiency (piracetam and amphetamine). Moreover, drug therapies for aphasia were less efficient alone than when they were associated with speech therapy.

Original languageEnglish
Pages (from-to)114-125
Number of pages12
JournalBrain and Language
Issue number1
Publication statusPublished - Jul 2007


  • Aphasia
  • Drug therapy
  • Pharmacological treatment
  • Pharmacotherapy
  • Stroke

ASJC Scopus subject areas

  • Language and Linguistics
  • Experimental and Cognitive Psychology
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)


Dive into the research topics of 'Pharmacotherapy of aphasia: Myth or reality?'. Together they form a unique fingerprint.

Cite this